(NASDAQ: KRON) Kronos Bio's forecast annual revenue growth rate of -17.74% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Kronos Bio's revenue in 2024 is $6,288,000.On average, 2 Wall Street analysts forecast KRON's revenue for 2024 to be $390,617,585, with the lowest KRON revenue forecast at $240,380,052, and the highest KRON revenue forecast at $540,855,117.
In 2025, KRON is forecast to generate $300,475,065 in revenue, with the lowest revenue forecast at $300,475,065 and the highest revenue forecast at $300,475,065.